By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AIMM Therapeutics 

Meibergdreef 59

Amsterdam    1105 BA  The Netherlands
Phone: 31-0-20-5665056 Fax: 31-0-20-5669168




Company News
AIMM Therapeutics Signs Exclusive License And Option Agreement With Merck & Co. (MRK), Kenilworth, NJ, U.S.A. On Preclinical Oncology Targets 8/2/2017 11:43:06 AM
AIMM Therapeutics’ Partner MedImmune (AZN) Starts Clinical Studies With RSV Antibody 7/2/2014 10:50:14 AM
AIMM Therapeutics' Pre-Fusion RSV Antibodies Facilitate Improved Approach to Vaccine Development 11/4/2013 10:41:40 AM
AIMM Therapeutics Significantly Strengthens Scientific Advisory Board with High Profile Appointments 6/20/2013 6:54:03 AM
AIMM Therapeutics in Strategic Partnership With Cosmo Pharmaceuticals S.p.A. to Combine Cosmo's Extended Release Technology & AIMM's High Quality Antibodies to Successfully Combat Gastrointestinal Disease 12/19/2012 9:41:54 AM
AIMM Therapeutics Appoints Former Head Novartis Research Institutes Jan de Vries CEO, and John Womelsdorf VP Business Development 11/8/2012 10:15:29 AM
AIMM Therapeutics Closes Financing Round With Life Sciences Fund Amsterdam 6/5/2009 11:08:41 AM